| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10969491 | Vaccine | 2012 | 10 Pages | 
Abstract
												⺠Recombinant modified vaccinia virus Ankara vectors express influenza H5N1 proteins. ⺠Mammalian virus-like particles (VLPs) containing influenza proteins are produced. ⺠VLPs are generated from recombinant MVA vectors expressing H5N1 hemagglutinin alone. ⺠Increased VLP production can be achieved if neuraminidase (NA) is co-expressed. ⺠VLPs elicit a protective immune response in a mouse challenge model.
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Immunology
												
											Authors
												Falko Schmeisser, Joan E. Adamo, Benjamin Blumberg, Rachel Friedman, Jacqueline Muller, Jackeline Soto, Jerry P. Weir, 
											